Home › Anal Cancer › Tennessee › Nashville
Anal Cancer clinical trials in Nashville, TN
4 studies for Anal Cancer are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Nashville
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
RecruitingPhase 1
- SCRI, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
SMP-3124LP in Adults With Advanced Solid Tumors
RecruitingPhase 1/2
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RecruitingPhase 1/2
- Tennessee Oncology, Nashville
About Anal Cancer
Anal cancer is rare. HPV is one of the most common causes. Find out more about anal cancer symptoms, diagnosis, and treatment.
More about Anal Cancer on MedlinePlus
Anal Cancer trials in other cities
- Houston, TX6 studies
- Los Angeles, CA5 studies
- Edison, NJ4 studies
- New York City, NY4 studies
- Chicago, IL3 studies
- Atlanta, GA3 studies
- Cleveland, OH3 studies
- San Francisco, CA3 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer96 studies
- Breast Cancer79 studies
- Metastatic Cancer69 studies
- Colorectal Cancer68 studies
- Cancer (all types)64 studies
- Ovarian Cancer48 studies
- Prostate Cancer43 studies
- Pancreatic Cancer40 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Endometrial Cancer37 studies
- Melanoma32 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.